The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans
Brain, Behavior, and Immunity · 2025-07 · 127 · 287-302
DOI: 10.1016/j.bbi.2025.03.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2025-07. Verfasst von Robert A J Byrne und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hodge Centre for Neuropsychiatric Immunology, School of Medicine, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff, Wales CF24 4HQ, UK;…. Hauptthemen laut MEDLINE: Astrocytes, Schizophrenia, Membrane Proteins, Complement Pathway, Classical. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Dementia Research Institute, Medical Research Council.
Abstract (Originalsprache)
CUB and sushi multiple domains 1 (CSMD1) is predominantly expressed in brain and robustly associated with schizophrenia risk; however, understanding of which cells express CSMD1 in brain and how it impacts risk is lacking. CSMD1 encodes a large transmembrane protein including fifteen tandem short consensus repeats (SCRs), resembling complement C3 convertase regulators. CSMD1 complement regulatory activity has been reported and mapped to SCR17-21. We expressed two SCR domains of CSMD1, SCR17-21 and SCR23-26, and characterised their complement regulatory activity using a panel of functional assays testing convertase and terminal pathway inhibition. Both domains inhibited the classical pathway C3 convertase by acting as factor I cofactors; neither domain caused any inhibition in alternative or terminal pathway assays. Novel anti-CSMD1 monoclonal antibodies cross-reactive with human and mouse CSMD1 were generated that detected endogenous CSMD1 in human and rodent brain; immunostaining showed predominantly astrocyte and synaptic localisation of CSMD1, the latter confirmed using isolated synapses. Using iPSC-derived cells, astrocyte expression was confirmed and expression on cortical neurons demonstrated. We show that CSMD1 is a classical pathway-specific complement regulator expressed predominantly on astrocytes, neurons, and synapses in human and mouse brain. These findings will help reveal the mechanism by which CSMD1 impacts schizophrenia risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hodge Centre for Neuropsychiatric Immunology, School of Medicine, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff, Wales CF24 4HQ, UK; UK Dementia Research Institute, School of Medicine, Cardiff Universit…
- UK Dementia Research Institute, School of Medicine, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff, Wales CF24 4HQ, UK; Division of Infection and Immunity, School of Medicine, Cardiff University, Henry W…
- Division of Infection and Immunity, School of Medicine, Cardiff University, Henry Wellcome Building, Heath Park, Cardiff, Wales CF14 4XN, UK.
- Hodge Centre for Neuropsychiatric Immunology, School of Medicine, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff, Wales CF24 4HQ, UK; Centre for Neuropsychiatric Genetics and Genomics, School of Medicine…
Förderung
- UK Dementia Research Institute
- Medical Research Council
Zitieren
APA
Byrne, R. A. J., Nimmo, J., Torvell, M., Carpanini, S. M., Daskoulidou, N., Hughes, T. R., Noble, L. V., Veteleanu, A., Watkins, L. M., Zelek, W. M., O'Donovan, M. C., & Morgan, B. P. (2025). The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans. Brain, Behavior, and Immunity, 127, 287-302. https://doi.org/10.1016/j.bbi.2025.03.026
Vancouver
Byrne RAJ, Nimmo J, Torvell M, Carpanini SM, Daskoulidou N, Hughes TR, et al. The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans. Brain, Behavior, and Immunity. 2025;127:287-302. doi:10.1016/j.bbi.2025.03.026
BibTeX
@article{Byrne2025,
author = {Byrne, Robert A J and Nimmo, Jacqui and Torvell, Megan and Carpanini, Sarah M and Daskoulidou, Nikoleta and Hughes, Timothy R and Noble, Lucy V and Veteleanu, Aurora and Watkins, Lewis M and Zelek, Wioleta M and O'Donovan, Michael C and Morgan, Bryan Paul},
title = {The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans},
journal = {Brain, Behavior, and Immunity},
year = {2025},
volume = {127},
pages = {287--302},
doi = {10.1016/j.bbi.2025.03.026}
}
EUVIMED